EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of GLP-1 Receptor Agonist Therapy on Outcomes in Hidradenitis Suppurativa: A TriNetX Database Study

Sean Frisbie, Diwakar Phuyal, Emanuella Brito, Chinenye Ogbonnah, James Gaston, Risal Djohan, Eliana Duraes

SKIN The Journal of Cutaneous Medicine · 10.11.2026 · 10 (6) · 3491-3495

DOI: 10.25251/5swch621 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SKIN The Journal of Cutaneous Medicine, online erschienen am 10.11.2026. Verfasst von Sean Frisbie und 6 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hidradenitis Suppurativa is a chronic inflammatory disorder strongly associated with obesity and metabolic dysfunction.1 Glucagon-like peptide-1 receptor agonists (GLP-1RA) demonstrate weight-loss and anti-inflammatory effects that may influence postoperative healing.1-3 We evaluated postoperative complications following hidradenitis excision among patients receiving GLP-1RA therapy compared with non-users.

Methods

This retrospective cohort study analyzed patients within the TriNetX database, aggregating electronic medical records and claims data from 70 healthcare organizations representing over 101 million patients. Included patients underwent hidradenitis excision involving the axillary (CPT-11450, CPT-11451), perianal/perineal/umbilical (CPT-11470, CPT-11471), or inguinal regions (CPT-11462, CPT-11463). Cohorts were stratified by preoperative GLP-1RA use, including Semaglutide, Tirzepatide, Liraglutide, Dulaglutide, or Exenatide, prescribed up to one day prior to surgery. One-to-one propensity score matching was performed for age, sex, race, ethnicity, comorbidities, HS-related procedures, and immunosuppressive therapy. Outcomes assessed at 1 and 3 months postoperatively included infection, debridement, reoperation, wound dehiscence, sepsis, thromboembolic events, emergency department visits, and overall complications. Reoperation was defined as repeat hidradenitis excision occurring ≥1 day after index surgery.

Results

After propensity score matching, 2,992 patients were included (1,496 per cohort), with balanced baseline characteristics (standardized mean differences

Zitieren

APA

Frisbie, S., Phuyal, D., Brito, E., Ogbonnah, C., Gaston, J., Djohan, R., & Duraes, E. (2026). Impact of GLP-1 Receptor Agonist Therapy on Outcomes in Hidradenitis Suppurativa: A TriNetX Database Study. SKIN The Journal of Cutaneous Medicine, 10(6), 3491-3495. https://doi.org/10.25251/5swch621

Vancouver

Frisbie S, Phuyal D, Brito E, Ogbonnah C, Gaston J, Djohan R, et al. Impact of GLP-1 Receptor Agonist Therapy on Outcomes in Hidradenitis Suppurativa: A TriNetX Database Study. SKIN The Journal of Cutaneous Medicine. 2026;10(6):3491-3495. doi:10.25251/5swch621

BibTeX
@article{Frisbie2026,
  author = {Frisbie, Sean and Phuyal, Diwakar and Brito, Emanuella and Ogbonnah, Chinenye and Gaston, James and Djohan, Risal and Duraes, Eliana},
  title = {Impact of GLP-1 Receptor Agonist Therapy on Outcomes in Hidradenitis Suppurativa: A TriNetX Database Study},
  journal = {SKIN The Journal of Cutaneous Medicine},
  year = {2026},
  volume = {10},
  number = {6},
  pages = {3491--3495},
  doi = {10.25251/5swch621}
}
Kostenlos starten →